insights_auto
Why is 603259 down ၆.၆၀%?
Dive Deeperchevron_right
603259:SHA
WuXi AppTec Co Ltd
၁၄၄.၃၀ CN¥
arrow_downward
-၆.၆၀%(-၁၀.၂၀) 1D
အောက် ၁၆, GMT+၈ ၁၅:၀၀:၀၁ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 603259...
Open
၁၅၆.၉၄ CN¥
High
၁၅၉.၉၂ CN¥
Low
၁၃၉.၀၅ CN¥
Mkt. cap
ဋေ ၄.၄၇ သ
Avg. vol.
၃.၄၀ ကုဋေ
Volume
၈.၃၆ ကုဋေ
Dividend
၁.၄၅%
Quarterly dividend
၀.၅၂ CN¥
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၁၉.၆၃
52-wk high
၁၇၃.၆၀ CN¥
52-wk low
၈၇.၀၉ CN¥
EPS
၇.၃၅ CN¥
Shares outstanding
၁၀၄.၈၃ ဋေ
No. of employees
၄ သောင်း
Open
၁၅၆.၉၄ CN¥
High
၁၅၉.၉၂ CN¥
Low
၁၃၉.၀၅ CN¥
Mkt. cap
ဋေ ၄.၄၇ သ
Avg. vol.
၃.၄၀ ကုဋေ
Volume
၈.၃၆ ကုဋေ
Dividend
၁.၄၅%
Quarterly dividend
၀.၅၂ CN¥
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၁၉.၆၃
52-wk high
၁၇၃.၆၀ CN¥
52-wk low
၈၇.၀၉ CN¥
EPS
၇.၃၅ CN¥
Shares outstanding
၁၀၄.၈၃ ဋေ
No. of employees
၄ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅ နာရီ
WuXi AppTec earns EcoVadis gold: what it means for WuXi AppTec stock
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees၃.၅၆ သောင်း
Founded၂၀၀၀ ဒီ ၁
Headquarters-
Sector-
Websitewuxiapptec.com.cn